Please assess the completion status of the following clinical trial:

Trial Title: Fecal Transplantation for Inflammatory Bowel Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Signed informed consent~2. Inflammatory bowel disease diagnosed at least 3 months ago~3. Failure of either one immunomodulator of at least 3 months duration, or TNF inhibitor full induction treatment, or intolerance to either of these drugs.~4. Currently active disease, partial Mayo score ≥4 for ulcerative colitis, or CDAI ≥200 for CD.~5. negative HIV , HTLV I/II, negative stool culture, Negative C diff toxin, negative CMV~Exclusion Criteria:~1. No informed consent~2. Non active inflammatory bowel disease.~3. Active infection in either the donor or the recipient,

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Fecal microbial l transplantation (Type: EXPERIMENTAL): patients with active colitis who will undergo treatment by fecal microbial transplantation

Based on this trial design, predict the completion outcome and termination type (if applicable).